tradingkey.logo
tradingkey.logo
Search

Stevanato Group SpA

STVN
Add to Watchlist
17.990USD
0.0000.00%
Close 05/15, 16:00ETQuotes delayed by 15 min
4.91BMarket Cap
40.13P/E TTM

Stevanato Group SpA

17.990
0.0000.00%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

-1.32%

1 Month

+19.69%

6 Months

-18.52%

Year to Date

-10.59%

1 Year

-25.10%

TradingKey Stock Score of Stevanato Group SpA

Currency: USD Updated: 2026-05-15

Key Insights

Stevanato Group SpA's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 36 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 25.49.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stevanato Group SpA's Score

Industry at a Glance

Industry Ranking
36 / 206
Overall Ranking
114 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Stevanato Group SpA Highlights

StrengthsRisks
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 12.27%.
Undervalued
The company’s latest PE is 40.13, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.73M shares, decreasing 27.47% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 987.00 shares of this stock.

Analyst Rating

Based on 11 analysts
Buy
Current Rating
25.493
Target Price
+42.74%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Stevanato Group SpA News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Stevanato Group SpA Info

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Ticker SymbolSTVN
CompanyStevanato Group SpA
CEOStevanato (Franco)
Websitehttps://www.stevanatogroup.com/
KeyAI